Linneo Health and Phytocontrol Group sign exclusive collaboration

Linneo Health, a global leader in the research, cultivation and supply of cannabis to improve human health and wellbeing, and Phytocontrol, an international group of laboratories providing a complete range of analysis in agri-food, water and biopharma, today announce that they have signed an exclusive clinical analysis collaboration agreement. The agreement gives Linneo Health access to Phytocontrol’s leading clinical analysis capabilities and allows both businesses to progress new developments and collaborations within the medicinal cannabis sector.

More information on the press release ?